Planet Fitness PLNT Evaluating the LowCost Gym Chains LongTerm Value Proposition
Trump Signals No Rush on Iran Nuclear Deal Naval Blockade to Continue
Piper Sandler Warns Strait of Hormuz Closure Could Drive Oil Prices to Historic Levels
Health Ministry Reclassifies CNS Drug Pregabalin to Schedule H1 to Curb Misuse
Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting Two Former Bed Bath Beyond Retailers
Alain Prost Injured in Home Raid Near Geneva Security Concerns for HighProfile Figures
ReNew Energy Global plc RNW Q1 2026 Earnings EPS Surges Past Estimates as Profitability Improves
Presurance Holdings Q1 2024 Earnings Surprise Profit Beats Estimates But Shares Slide on Revenue Disclosures
Security National Financial Corporation SNFCA Q4 2025 Earnings Profitability Maintained Amid Mixed Market Signals
DVLT Q1 2026 Earnings EPS Misses Estimates Amid Continued Operating Losses
TC Energy Q1 2026 Earnings InLine EPS Slightly Misses Estimate Stock Edges Higher
VERX Q1 2026 Earnings EPS Slightly Beats Estimates Stock Gains Modestly
Tetra Tech TTEK Edges Higher as Stock Holds Above Key Support
Rio Tinto RIO Slides 115 as Commodity Headwinds Persist Support at 10042 in Focus
Gladstone Commercial Preferred Stock GOODO Holds Steady Near 20 Amidst Stability
Enviri Corporation NVRI Surges 578 as Shares Test Key Resistance Zone
CEA Industries Inc BNC Holds Steady Near Support as Shares Edge Higher
Enterprise Financial Services EFSCP Q1 2026 Earnings Narrow EPS Miss Amid Market Optimism
ONE Gas Q1 2026 Earnings EPS Falls Short of Estimates as Operating Environment Challenges Persist
SSB Q1 2026 Earnings EPS Beats Estimates Amid Stable Banking Operations
Wells Fargo Q1 2026 Earnings Slight EPS Beat Amid Steady Operating Performance
MGPI Q1 2026 Earnings EPS Surges Past Estimates with 30872 Surprise
JFIN Q4 2024 Earnings Reports EPS of 523 Amid Market Volatility
As Gas Prices Hit 455 Drivers Explore FuelSaving Strategies Ahead of Busy Travel Weekend
RDI Q3 2025 Earnings EPS Misses Estimates Amid Operational Challenges
Enliven Therapeutics ELVN Slips 19 as Stock Tests Key Support Near 3858